Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 2
After 25 years of drug development, do we know JAK?
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Rheumatoid arthritis
Viewpoint
After 25 years of drug development, do we know JAK?
Online download statistics by month:
Online download statistics by month: July 2022 to March 2024
Abstract
Full
Pdf
Jul 2022
726
730
303
Aug 2022
1077
1084
312
Sep 2022
428
429
144
Oct 2022
299
301
134
Nov 2022
179
171
90
Dec 2022
112
106
50
Jan 2023
152
147
29
Feb 2023
121
118
47
Mar 2023
125
123
57
Apr 2023
103
100
47
May 2023
112
109
31
Jun 2023
113
113
41
Jul 2023
215
210
42
Aug 2023
145
144
46
Sep 2023
85
86
32
Oct 2023
89
87
22
Nov 2023
98
97
44
Dec 2023
66
70
29
Jan 2024
38
38
7
Feb 2024
30
27
15
Mar 2024
66
64
34
Total
4379
4354
1556
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF